Life Spine's latest FDA clearance and five more updates from spine medtech companies in the last week:
Spinal Tech
Many exciting innovations are being developed in the spine device industry, with smaller companies and startups aiming to break into a market dominated by medtech giants such as Medtronic, Stryker and Johnson & Johnson.
Five spine and orthopedic medtech companies completed or announced acquisitions in the first quarter of 2022.
Life Spine's sacroiliac joint fixation system, SImpact, received FDA clearance for posterior-oblique surgical approaches, the devicemaker said March 29.
The FDA granted nine orthopedic device approvals in February:
CFOs hold the top financial position in a company and are responsible for projecting the organization's financial standing as well as advising the CEO and board on strategic direction.
From the separation of its spine and dental businesses to its latest commercial product launch, here are four key developments from Zimmer Biomet in the first quarter:
France-based Spine Innovations reached a milestone with its lumbar disc replacement device, and it's setting its sights on the U.S. market.
Globus Medical co-founder Andrew Iott is among two new additions to Happe Spine's board of directors.
A $3.1 billion acquisition and four more developments from Stryker in the first quarter of 2022:
